IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 208 filers reported holding IMMUNOMEDICS INC in Q2 2019. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $6,496,000 | -83.9% | 76,398 | -93.3% | 0.01% | -85.1% |
| Q2 2020 | $40,279,000 | +253.9% | 1,136,549 | +34.6% | 0.09% | +203.2% |
| Q1 2020 | $11,381,000 | -34.1% | 844,289 | +3.5% | 0.03% | -13.9% |
| Q4 2019 | $17,266,000 | +107.3% | 815,969 | +29.9% | 0.04% | +100.0% |
| Q3 2019 | $8,327,000 | -43.6% | 627,954 | -41.1% | 0.02% | -43.8% |
| Q2 2019 | $14,777,000 | -15.4% | 1,065,347 | +17.2% | 0.03% | -17.9% |
| Q1 2019 | $17,463,000 | -14.7% | 909,048 | -36.7% | 0.04% | -23.5% |
| Q4 2018 | $20,480,000 | -31.4% | 1,435,204 | +0.1% | 0.05% | -16.4% |
| Q3 2018 | $29,851,000 | -5.4% | 1,433,071 | +7.4% | 0.06% | -9.0% |
| Q2 2018 | $31,571,000 | +4669.0% | 1,333,820 | +2844.1% | 0.07% | +6600.0% |
| Q1 2018 | $662,000 | -11.3% | 45,305 | -1.9% | 0.00% | -50.0% |
| Q4 2017 | $746,000 | +5.8% | 46,192 | -8.4% | 0.00% | 0.0% |
| Q3 2017 | $705,000 | +58.4% | 50,433 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $445,000 | +44.5% | 50,433 | +5.9% | 0.00% | 0.0% |
| Q1 2017 | $308,000 | +76.0% | 47,625 | 0.0% | 0.00% | – |
| Q4 2016 | $175,000 | +12.9% | 47,625 | 0.0% | 0.00% | – |
| Q3 2016 | $155,000 | +28.1% | 47,625 | -8.6% | 0.00% | – |
| Q2 2016 | $121,000 | -21.4% | 52,087 | -15.5% | 0.00% | – |
| Q1 2016 | $154,000 | -18.5% | 61,662 | 0.0% | 0.00% | – |
| Q4 2015 | $189,000 | +78.3% | 61,662 | 0.0% | 0.00% | – |
| Q3 2015 | $106,000 | -57.6% | 61,662 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $250,000 | +5.9% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $236,000 | -20.3% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $296,000 | +29.3% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $229,000 | +1.8% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $225,000 | -13.5% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $260,000 | -8.5% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $284,000 | -25.7% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $382,000 | +14.0% | 61,662 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $335,000 | – | 61,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 17,714,461 | $368,992,000 | 16.94% |
| ACUTA CAPITAL PARTNERS, LLC | 2,055,500 | $42,816,000 | 15.27% |
| Foresite Capital Management III, LLC | 2,691,729 | $56,069,000 | 12.37% |
| Foresite Capital Management IV, LLC | 1,231,543 | $25,653,000 | 8.41% |
| NEXTHERA CAPITAL LP | 1,398,577 | $29,132,000 | 5.58% |
| Palo Alto Investors LP | 5,013,764 | $104,437,000 | 4.22% |
| Ghost Tree Capital, LLC | 883,823 | $18,410,000 | 3.91% |
| First Light Asset Management, LLC | 1,151,622 | $23,988,000 | 3.87% |
| DLD Asset Management, LP | 3,403,000 | $70,918,000 | 3.51% |
| RA Capital Management | 3,119,778 | $64,985,000 | 3.47% |